Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Development of Drugs on Endothelial Cell Protection for Overcoming CKD
Chronic kidney disease (CKD) is becoming a major public health problem worldwide. It is important to protect endothelial function in CKD treatment because injury of the endothelium is a critical event for the generation and progression of CKD. Recently, clinical studies showed that nifedipine, an an...
Saved in:
Main Authors: | Keisuke Ishizawa (Author), Kunihisa Yamaguchi (Author), Yuya Horinouchi (Author), Yayoi Fukuhara (Author), Soichiro Tajima (Author), Shuichi Hamano (Author), Shuhei Tomita (Author), Koichiro Tsuchiya (Author), Toshiaki Tamaki (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): New Therapy for CKD by a (Pro)Renin-Receptor-Blocking Decoy Peptide
by: Atsuhiro Ichihara, et al.
Published: (2009) -
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): The Endothelin ETB Receptor / Nitric Oxide System Functions as a Protective Factor in CKD
by: Mamoru Ohkita, et al.
Published: (2009) -
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Pharmacological Effects of Mineralocorticoid-Receptor Blockers
by: Akira Nishiyama, et al.
Published: (2009) -
Pathophysiological Response to Hypoxia - From the Molecular Mechanisms of Malady to Drug Discovery: Inflammatory Responses of Hypoxia-Inducible Factor 1α (HIF-1α) in T Cells Observed in Development of Vascular Remodeling
by: Shuhei Tomita, et al.
Published: (2011) -
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD
by: Tetsuhiro Tanaka, et al.
Published: (2009)